US FDA approves Zevra's treatment for rare genetic disease
Go back to US FDA approves Zevra's treatment for rare genetic disease| (NASDAQ: ZVRA) | Delayed: 11.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.74 | 52 Week High | $ | |||
| Open | $11.74 | 52 Week Low | $ | |||
| Day High | $11.74 | P/E | N/A | |||
| Day Low | $11.74 | EPS | $ | |||
| Volume | 24 | |||||
